Source:http://linkedlifedata.com/resource/pubmed/id/18698826
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
18
|
| pubmed:dateCreated |
2008-9-15
|
| pubmed:abstractText |
An efficient enantioselective synthesis of (+)-isofregenedol was achieved in 13 steps from commercially available cyclohexene oxide without the use of protecting groups. The tetrahydronaphthalenic core of isofregenedol was obtained via a gold(I)-catalyzed benzannulation recently developed in our laboratory.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
1520-6904
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:day |
19
|
| pubmed:volume |
73
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
7436-9
|
| pubmed:meshHeading | |
| pubmed:year |
2008
|
| pubmed:articleTitle |
De novo synthesis of (+)-isofregenedol.
|
| pubmed:affiliation |
Department of Chemistry, 10 Marie Curie, University of Ottawa, Ottawa, Canada K1N 6N5.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|